New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
11:47 EDTESI, FLIR, PCL, LH, DNB, SNTAHigh option volume stocks: DNB ESI PCL SNTA FLIR LH
News For LH;FLIR;SNTA;PCL;ESI;DNB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
15:57 EDTLHLabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
September 30, 2015
08:46 EDTLHLabCorp's Bode Cellmark enters service pact with DANY
Subscribe for More Information
September 22, 2015
07:41 EDTPCLRaymond James to hold a conference
North American Equities Conference to be held in London, England on September 22.
September 21, 2015
17:15 EDTESIITT Educational receives CID from DoJ
The Company announced that it has received a Civil Investigative Demand from the U.S. Department of Justice. The CID provides that the purpose of the investigation is "to determine whether there is or has been a violation of and is "focused on whether [the Company] knowingly submitted false statements in violation of the Department of Education's Program Participation Agreement regulations." The CID contains requests for production of documents and answers to interrogatories which the Company believes are principally related to the Company's compliance with the U.S. Department of Education's compensation regulations. The Company believes that its practices with respect to compensation matters are in compliance with applicable laws and regulations, and is cooperating with the DOJ in responding to the CID.
September 20, 2015
13:59 EDTLHOPKO Health may face challenge with Bio-Reference acquisition, Barron's says
OPKO Health (OPK) "could face a big challenge" with its acquisition of Bio-Reference, Barron's contends in its 'Follow Up' column. Barron's conducted recent interviews with former Bio-Reference salespeople, who allege that the company pushed expensive, unnecessary tests on patients, resulting in pushback from health insurers. Additionally, the former employees claim the company was willing to waive patient co-payments in order to better compete with LabCorp (LH) and Quest Diagnostics (DX), says Barron's. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use